Sanofi seeks expansion in diagnostics space

Sanofi ($SNY) wants to expand its diagnostics business, CEO Chris Viehbacher disclosed in a recent Bloomberg interview. The French drugmaker is looking to jump into the space with an eye, in part, on rivals such as Roche ($RHHBY), which continues to strengthen and grow its diagnostics arm. But Sanofi won't get there the same way. Veihbacher told Bloomberg that Sanofi needs "to be active in diagnostics [and] biomarkers, but I think we will do that through partnerships, not acquisitions." Story

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.